Molecular mechanisms underlying skeletal muscle weakness in human cancer: reduced myosin-actin cross-bridge formation and kinetics.
about
Molecular Background of miRNA Role in Asthma and COPD: An Updated InsightDiscerning primary and secondary factors responsible for clinical fatigue in multisystem diseasesSkeletal muscle myofilament adaptations to aging, disease, and disuse and their effects on whole muscle performance in older adult humansTumor growth increases neuroinflammation, fatigue and depressive-like behavior prior to alterations in muscle function.Random myosin loss along thick-filaments increases myosin attachment time and the proportion of bound myosin heads to mitigate force decline in skeletal muscle.Age-related structural alterations in human skeletal muscle fibers and mitochondria are sex specific: relationship to single-fiber functionEpigenetic mechanisms in respiratory muscle dysfunction of patients with chronic obstructive pulmonary diseaseExercise-based oncology rehabilitation: leveraging the cardiac rehabilitation model.Molecular determinants of force production in human skeletal muscle fibers: effects of myosin isoform expression and cross-sectional areaChronic disuse and skeletal muscle structure in older adults: sex-specific differences and relationships to contractile function.Metalloproteinase expression is altered in cardiac and skeletal muscle in cancer cachexiaMotor protein function in skeletal abdominal muscle of cachectic cancer patients.Bone Pain and Muscle Weakness in Cancer Patients.Moderate-intensity resistance exercise alters skeletal muscle molecular and cellular structure and function in inactive older adults with knee osteoarthritis.Improvement of skeletal muscle performance in ageing by the metabolic modulator TrimetazidineRole of PARP activity in lung cancer-induced cachexia: Effects on muscle oxidative stress, proteolysis, anabolic markers, and phenotype.Short- and Long-Term Hindlimb Immobilization and Reloading: Profile of Epigenetic Events in Gastrocnemius.
P2860
Q26744763-A23ABA65-1CB2-4507-BA8E-8B4BB8421E2FQ26866364-6CFB6F66-2884-4EB0-90A9-43730A3AD6CCQ27026517-52E3DD0C-3746-46CA-AB1F-966C107522E8Q27331924-2DCC29AB-04B9-44BD-949E-01CA726A672DQ33707251-40B5DB40-71E6-4F7C-99AD-1BBA751973D7Q33781333-F39585AE-A4E3-4D70-9273-7B2287C892D5Q34450490-7B5BBC9E-0A43-4C24-B836-BBD521C04CFAQ35126032-8C6D42B5-8FAF-4E82-95CC-BF979A854C41Q35178601-3C891229-F643-45C0-9967-6F109F59C45FQ35671889-3F4191D0-352F-4840-BF30-A13BA2D6C55FQ35958613-066B9C4A-DA9F-4F80-BEE7-25712E3B91D9Q37562334-2BBD0960-028F-40E9-9F0A-8CFE955A8672Q38684768-4E166C6E-4BB4-44C5-A2C8-5981DA1A2191Q39023714-AEFC6365-7303-4635-BA84-23230EBDC220Q42793119-2E6916B7-0652-43EC-BA4F-897EFB0AF2C0Q47979117-16AB1EAA-126D-4639-B8ED-C989BDAAC651Q50226668-E6BE7895-67CA-476B-B007-8E684A3E7005
P2860
Molecular mechanisms underlying skeletal muscle weakness in human cancer: reduced myosin-actin cross-bridge formation and kinetics.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Molecular mechanisms underlyin ...... bridge formation and kinetics.
@en
type
label
Molecular mechanisms underlyin ...... bridge formation and kinetics.
@en
prefLabel
Molecular mechanisms underlyin ...... bridge formation and kinetics.
@en
P2093
P2860
P1476
Molecular mechanisms underlyin ...... bridge formation and kinetics.
@en
P2093
Andrew P Sweeny
Damien M Callahan
Hirak Der-Torossian
Ivette Nunez
Kim Dittus
Marion E Couch
Mark S Miller
Michael J Toth
Steven M Grunberg
P2860
P304
P356
10.1152/JAPPLPHYSIOL.01474.2012
P407
P577
2013-02-14T00:00:00Z